Home > Healthcare > Medical Devices > Diagnostic Devices > Anthrax Vaccine Market

Anthrax Vaccine Market Trends

Report ID: GMI9546
Published Date: May 2024
Report Format: PDF

Download Free Sample

Anthrax Vaccine Market Trends

The global burden of anthrax is a significant concern, with estimates indicating a substantial impact on both human and livestock populations.
Studies suggest that anthrax remains a disease of public health importance, particularly in regions with agricultural economies, where multiple outbreaks have demonstrated high morbidity and low mortality rates. For instance, in July 2022, Croatia reported an outbreak of anthrax infections. There were 17 reported human cases of cutaneous anthrax and 29 laboratory-confirmed animal cases.
Additionally, the increasing incidence of anthrax in humans, particularly in regions where the disease is endemic or where there is a higher risk of exposure, has led to a greater demand for anthrax vaccines.
Governments, public health agencies, and biopharmaceutical companies are therefore focusing on the development and distribution of anthrax vaccines to protect populations at risk, thereby stimulating the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for anthrax vaccine was worth USD 11.9 billion in 2023 and is projected to expand at 5.4% CAGR from 2024 to 2032, due to the increasing awareness about anthrax as a potential bioterrorism threat.

The cell free PA vaccine segment in the anthrax vaccine industry reached USD 6.7 billion in 2023 and is projected to expand at substantial rate from 2024 to 2032, owing to the improved safety profiles compared to whole-cell vaccines.

The veterinary use segment in the anthrax vaccine industry held 81.8% share in 2023 and is estimated to witness robust growth between 2024 and 2032, due to the rising need to prevent the spread of anthrax in animal populations, protecting both animals and humans from the disease.

North America industry recorded USD 4.7 billion in revenue in 2023 and is estimated to depict significant growth between 2024 to 2032, on account of the growing awareness among livestock animal caretakers regarding their immunization against anthrax.